These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Characterization of anti-acetylcholine receptor antibody activity in patients with anti-mitochondrial antibodies. Sundewall AC, Lefvert AK, Norberg R. Clin Immunol Immunopathol; 1987 Nov; 45(2):184-95. PubMed ID: 3665199 [Abstract] [Full Text] [Related]
23. Anti-idiotypic antibodies, acetylcholine receptor antibodies and disturbed neuromuscular function in healthy relatives to patients with myasthenia gravis. Lefvert AK, Pirskanen R, Svanborg E. J Neuroimmunol; 1985 Jul; 9(1-2):41-53. PubMed ID: 4008636 [Abstract] [Full Text] [Related]
24. Treatment of myasthenia gravis by preventing acetylcholine receptor modulation. Losen M, Martínez-Martínez P, Phernambucq M, Schuurman J, Parren PW, De Baets MH. Ann N Y Acad Sci; 2008 Jul; 1132():174-9. PubMed ID: 18567867 [Abstract] [Full Text] [Related]
26. Myasthenia gravis: a model disorder of acetylcholine receptors. Drachman DB. Res Publ Assoc Res Nerv Ment Dis; 1987 Jul; 65():65-82. PubMed ID: 3330842 [No Abstract] [Full Text] [Related]
27. [Conceptual aspects of myasthenia gravis]. Ledro Molina D, Avilés Mejías S, Garrido Peralta M. Rev Clin Esp; 1981 Oct 15; 163(1):13-6. PubMed ID: 6276939 [No Abstract] [Full Text] [Related]
28. Cellular production of antibodies related to the acetylcholine receptor in myasthenia gravis: correlation with clinical stage. Lefvert AK, Holm G, Sundén H, Pirskanen R. Scand J Immunol; 1987 Mar 15; 25(3):265-73. PubMed ID: 2436288 [Abstract] [Full Text] [Related]
30. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis. Kawanami S, Tsuji R, Oda K. Ann Neurol; 1984 Feb 15; 15(2):195-200. PubMed ID: 6367620 [Abstract] [Full Text] [Related]
31. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction. Cole RN, Reddel SW, Gervásio OL, Phillips WD. Ann Neurol; 2008 Jun 15; 63(6):782-9. PubMed ID: 18384168 [Abstract] [Full Text] [Related]
32. Humoral immunity in myasthenia gravis: immunoglobulin class, affinity, and antigenic site. Tindall RS. Trans Am Neurol Assoc; 1979 Jun 15; 104():16-8. PubMed ID: 553397 [No Abstract] [Full Text] [Related]
33. Molecular and structural characterization of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis. Graus YM, De Baets MH. Adv Neuroimmunol; 1994 Jun 15; 4(4):457-74. PubMed ID: 7719618 [No Abstract] [Full Text] [Related]
34. [Myasthenia gravis (1). Experimental myasthenia gravis--a tool for the study of the pathogenesis, diagnosis and treatment of myasthenia gravis]. Heilbronn E. Lakartidningen; 1978 Oct 11; 75(41):3663-4, 3669. PubMed ID: 692231 [No Abstract] [Full Text] [Related]
35. Anti-idiotypic antibodies against the receptor antibodies in myasthenia gravis. Lefvert AK. Scand J Immunol; 1981 Oct 11; 13(5):493-7. PubMed ID: 7313551 [Abstract] [Full Text] [Related]
36. Binding affinities of anti-acetylcholine receptor autoantibodies in myasthenia gravis. Bray JJ, Drachman DB. J Immunol; 1982 Jan 11; 128(1):105-10. PubMed ID: 7054275 [No Abstract] [Full Text] [Related]
37. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A. Szpirt W, Somnier F, Nielsen FC, Rødgaard A. Life Support Syst; 1985 Jan 11; 3 Suppl 1():351-5. PubMed ID: 3916613 [No Abstract] [Full Text] [Related]